The pandemic pipeline

Nature Biotechnology
Volume 38 Issue 5, May 2020


News Feature | 20 March 2020
The pandemic pipeline
Companies are doing their best to accelerate experimental drugs and vaccines for COVID-19 through the pipeline. Each faces its own set of challenges, but all agree on the need for a radical rethink of the clinical development process for pandemics.
John Hodgson